Palmitoylisopropylamide, with the CAS number 189939-61-5, is a synthetic compound that belongs to the class of fatty acid amides. It is characterized by the presence of a palmitoyl group, which is derived from palmitic acid, a common saturated fatty acid, and an isopropylamide moiety. This compound is often studied for its potential biological activities, including its role in modulating various physiological processes. Palmitoylisopropylamide is known for its lipophilic nature, which may influence its absorption and distribution in biological systems. Additionally, it may exhibit properties such as anti-inflammatory effects and potential applications in dermatological formulations due to its ability to interact with skin receptors. The compound's stability, solubility, and compatibility with other ingredients are important factors in its formulation for cosmetic or therapeutic uses. Overall, palmitoylisopropylamide represents a fascinating area of research within the field of medicinal chemistry and cosmetic science.

PALMITOYLISOPROPYLAMIDE

189939-61-5: N-(1-Methylethyl)-Hexadecanamide, Palmitoyl N-Isopropylamide, N-Isopropyl-Hexadecanamide

Palmitoylisopropylamide is a molecule that has two amide groups. It also contains a hydroxyl group and a fatty acid chain. This molecule is an antagonist of the cannabinoid receptor type 2 (CB2). Palmitoylisopropylamide is able to inhibit coagulation factors in the blood by binding to polymerase chain, which prevents the formation of prothrombin. The inhibition of this enzyme leads to a decrease in the production of thrombin, which results in decreased blood clotting.

Palmitoylisopropylamide

Palmitoylisopropylamide is a selective FAAH inhibitor that inhibits [H]-AEA uptake and cell proliferation at low concentrations.

CAS 189939-61-5: PALMITOYLISOPROPYLAMIDE

Palmitoylisopropylamide

Ref: 3D-FP26735

Palmitoylisopropylamide

Ref: 54-BUP03782

Palmitoylisopropylamide

Ref: TM-T23119

Hexadecanamide, N-(1-methylethyl)-

Ref: IN-DA002E4W